NancyUan-TsinLinMD

Clinical Trials

• Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer Start of enrollment: 2007 May 14

  Active, not recruiting

  Phase 2

• Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer Start of enrollment: 2007 Apr 01

  Completed

  Phase 1

• ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases Start of enrollment: 2007 Jul 01

  Terminated

  Phase 2

• Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Start of enrollment: 2007 Nov 01

  Terminated

  Phase 3

• Carboplatin and Bevacizumab for Progressive Breast Cancer Brain Metastases Start of enrollment: 2009 Nov 01

  Completed

  Phase 2

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15

  Active, not recruiting

  Phase 3

• Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer Start of enrollment: 2011 Aug 01

  Completed

  Phase 1, Phase 2

• GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases Start of enrollment: 2011 Oct 01

  Completed

  Phase 2

• Fulvestrant With or Without Ganetespib in HR+ Breast Cancer Start of enrollment: 2012 May 01

  Active, not recruiting

  Phase 2

• A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer Start of enrollment: 2012 Jun 01

  Completed

  Phase 2

• BKM120 For Triple Negative Breast Cancer Start of enrollment: 2012 Jun 01

  Completed

  Phase 2

• ARRY-380 + Trastuzuamab for Breast w/ Brain Mets Start of enrollment: 2013 Aug 01

  Completed

  Phase 1

• Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer Start of enrollment: 2014 May 01

  Terminated

  Phase 1, Phase 2

• Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer Start of enrollment: 2016 Apr 07

  Completed

  Phase 2

• Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC Start of enrollment: 2018 May 21

  Active, not recruiting

  Phase 2

• Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer Start of enrollment: 2019 Sep 16

  Suspended

  Roles: Principal Investigator, Contact

• Join now to see all